Restless legs keeping you up? What the 2024 sleep-medicine guideline says
The American Academy of Sleep Medicine's 2024 restless legs guideline has 28 recommendations and reverses its 2012 stance on two common drugs. Plain answers.
In this article11 sections
It is 11 p.m., the alarm is set for six, and your legs will not settle. If that is a regular night for you, the American Academy of Sleep Medicine’s 2024 restless legs guideline matters, because it reversed a 2012 position on two of the most familiar drugs. What follows is general information, and the decisions belong to you and a clinician.
What did the 2024 AASM restless legs guideline change?
It issued 28 recommendations graded with the GRADE method, led by task force chair Dr. John Winkelman. The headline shift: pramipexole and ropinirole, which the Academy says carried strong recommendations in 2012, now carry conditional recommendations against their standard use.
Why were pramipexole and ropinirole pushed back?
The guideline’s concern is augmentation, which it says is often associated with long-term use of these dopamine agonists. In practice, augmentation means the medicine seems to work, then your symptoms start earlier in the day, grow stronger, or creep into your arms. If that sounds familiar, tell the prescriber. Stopping on your own is the wrong move.
What does the guideline favor now?
Gabapentin enacarbil, gabapentin and pregabalin each get a strong recommendation. So does intravenous ferric carboxymaltose for adults with appropriate iron status, and the guideline wants iron studies, including ferritin and transferrin saturation, checked in everyone with clinically significant restless legs. Ask whether yours were measured, because the oral-versus-IV decision depends on the numbers, and guessing with over-the-counter iron is a bad plan.
What can you change before any drug?
The authors put exacerbating factors first: alcohol, caffeine, certain antidepressants and antihistamines, and untreated obstructive sleep apnea. Two of those are in your hands tonight. How long a late coffee stays active is laid out in the caffeine cutoff piece, and what an evening drink does to the second half of the night is in the alcohol and sleep architecture write-up. Medication changes are a conversation for the prescriber, and a partner who says you snore is a reason to ask about apnea.
Who wrote it, and what did they disclose?
Dr. Winkelman disclosed steering committee work for Luitpold Pharmaceuticals and consulting for several other companies, including Emalex, Disc Medicine and Noctrix Health. The guideline strongly recommends IV ferric carboxymaltose. Neither fact proves bias, since recommendations are graded on trial evidence and the disclosure is public, but the full disclosure statement tells you which product each relationship concerns, and it is worth reading before you weigh the strongest iron recommendation.
Why does a leg problem turn into a morning problem?
Symptoms are usually worst in the evening and at night, which pushes sleep onset later. If the alarm stays put, the short night lands on your morning. That link is an inference from how the condition is typically described, and the guideline itself covers treatment only.
Quick answers
Is there a drug-free option in the guideline?
Yes. Bilateral high-frequency peroneal nerve stimulation received a conditional recommendation as a device-based option.
What does the guideline say for children?
It gives conditional support to ferrous sulfate and describes it as the only recommended pediatric treatment.
Where do opioids fit?
Low-dose, extended-release oxycodone and other low-dose opioids get a conditional recommendation for severe cases that have not responded to other treatments, with cautious use and clinical oversight.
Do the 2024 and 2025 dates mean two different guidelines?
No. The guideline went online as an accepted paper on September 26, 2024, and was scheduled for the January 1, 2025 issue of the Journal of Clinical Sleep Medicine. The Academy’s public announcement came on November 13, 2024.